title: Expression of functional prostaglandin D (DP) receptors in human corpus cavernosum smooth muscle.
abstract: Prostaglandin D(2) (PGD(2)) binds to specific G-protein coupled receptors (DP) and induces smooth muscle relaxation by stimulating the synthesis of intracellular cAMP. In this study, we examined the role of PGD(2) and DP receptors in regulating human penile smooth muscle contractility. We determined that human corpus cavernosum tissue and smooth muscle cells in culture expressed functional DP receptor and lipocalin-like prostaglandin D synthase by reverse-transcribed polymerase chain reaction (RT-PCR). Functional PGD synthase activity was confirmed by the synthesis of PGD(2) in human corpus cavernosum smooth muscle cells upon addition of exogenous arachidonic acid. Organ bath preparations of human corpus cavernosum tissue strips, contracted with phenylephrine, relaxed in a dose-dependent fashion to either PGD(2) or the DP selective agonist BW245C. Cultures of human corpus cavernosum smooth muscle cells treated with BW245C showed a two-fold increase in cAMP synthesis. These data are consistent with the expression of functional DP receptors in human corpus cavernosum. This suggests the presence of an intact prostanoid autocrine system that may play a role in regulating penile erectile function.
authors.affiliation: Department of Urology, Boston University School of Medicine, Boston, Massachusetts, USA. robert.moreland@abbott.com
authors.forename: R B
authors.initials: RB
authors.lastname: Moreland
authors.forename: A
authors.initials: A
authors.lastname: Nehra
authors.forename: N N
authors.initials: NN
authors.lastname: Kim
authors.forename: Kweon-Sik
authors.initials: KS
authors.lastname: Min
authors.forename: H
authors.initials: H
authors.lastname: Albadawi
authors.forename: M T
authors.initials: MT
authors.lastname: Watkins
authors.forename: I
authors.initials: I
authors.lastname: Goldstein
authors.forename: A M
authors.initials: AM
authors.lastname: Traish
mesh_terms: D019086:Bridged Bicyclo Compounds, Heterocyclic; D005231:Fatty Acids, Unsaturated; D006801:Humans; D006827:Hydantoins / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D010413:Penis / Q000187:drug effects / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D011971:Receptors, Immunologic; D011982:Receptors, Prostaglandin / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation
chemical_list: D019086:Bridged Bicyclo Compounds, Heterocyclic; D005231:Fatty Acids, Unsaturated; D006827:Hydantoins; D006834:Hydrazines; D012333:RNA, Messenger; D011971:Receptors, Immunologic; D011982:Receptors, Prostaglandin; C030669:BW 245C; C045749:SQ 29548; C036293:prostaglandin D2 receptor